Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - STOCK-BASED COMPENSATION
Stock-based Compensation ALNY - Alnylam Pharmaceuticals, Inc.
222 M
LAST VALUE
15.66%
2 YEAR CAGR
7.04%
5 YEAR CAGR
26.76%
10 YEAR CAGR